Advertisement
Canada markets closed
  • S&P/TSX

    24,890.68
    -158.99 (-0.63%)
     
  • S&P 500

    5,870.62
    -78.55 (-1.32%)
     
  • DOW

    43,444.99
    -305.87 (-0.70%)
     
  • CAD/USD

    0.7098
    -0.0017 (-0.23%)
     
  • CRUDE OIL

    66.95
    -1.75 (-2.55%)
     
  • Bitcoin CAD

    128,303.09
    +2,672.41 (+2.13%)
     
  • XRP CAD

    1.69
    +0.41 (+32.42%)
     
  • GOLD FUTURES

    2,567.40
    -5.50 (-0.21%)
     
  • RUSSELL 2000

    2,303.84
    -33.10 (-1.42%)
     
  • 10-Yr Bond

    4.4280
    +0.0100 (+0.23%)
     
  • NASDAQ

    18,680.12
    -427.53 (-2.24%)
     
  • VOLATILITY

    16.14
    +1.83 (+12.79%)
     
  • FTSE

    8,063.61
    -7.58 (-0.09%)
     
  • NIKKEI 225

    38,642.91
    +107.21 (+0.28%)
     
  • CAD/EUR

    0.6730
    -0.0022 (-0.33%)
     

IBD 50's TG Therapeutics Rises On Five-Year Data For Multiple Sclerosis Drug

IBD 50's TG Therapeutics Rises On Five-Year Data For Multiple Sclerosis Drug

TG Therapeutics stock rose Wednesday after the company unveiled promising five-year test results for its multiple sclerosis drug, Briumvi.